Abstracts & Presentations
International Conferences
2015 International Conferences
(By conference, by month, by author)
15th International Conference on Malignancies in AIDS and Other
Acquired Immunodeficiencies, Bethesda, Maryland, October 2015
Klingman K et al, Risk of both AIDS-related and non-AIDS-related
cancers decreased by early initiation of antiretroviral therapy:
results from the START trial (INSIGHT 001) --
Abstract |
Slides
17th International Workshop on Co-morbidities and Adverse Drug
Reactions in HIV, Barcelona, Spain, October 2015
Hoy J et al, Effects of immediate versus deferred initiation of
antiretroviral therapy on bone mineral density: a substudy of the
INSIGHT Strategic Timing of Antiretroviral Therapy (START) study --
Abstract |
Slides
Kunisaki K et al, Lung function decline in HIV: Effects of immediate
versus deferred ART treatment on lung function decline in a
multi-site, international, randomized controlled trial --
Abstract |
Slides
Wendt CH et al - The metabolome in HIV-associated chronic obstructive
pulmonary disease --
Abstract |
Slides
15th European AIDS Conference, Barcelona, Spain, October 2015
Grint D et al, The natural history of HCV-RNA among HIV/HCV coinfected
individuals in the ESPRIT study; documented spontaneous clearance in 9
individuals with CC and CT IL28B genotypes --
Abstract |
Poster
Hoy J et al, Effects of immediate versus deferred initiation of
antiretroviral therapy on bone mineral density: a substudy of the
INSIGHT Strategic Timing of Antiretroviral Therapy (START) study --
Abstract |
Slides
Kunisaki K et al, Lung function decline in HIV: Effects of immediate
versus deferred ART treatment on lung function decline in a
multi-site, international, randomized controlled trial --
Abstract |
Slides
Wendt CH et al - The metabolome in HIV-associated chronic obstructive
pulmonary disease --
Abstract |
Poster
Wright E (Price R, presenting) et al - No difference between the
effects of immediate versus deferred ART on neuropsychological test
performance in HIV-positive adults with CD4+ cell counts above 500
cells/5L: the Strategic Timing of AntiRetroviral Treatment (START)
Neurology Substudy --
Abstract |
Slides
8th IAS Conference on Pathogenesis, Treatment and Prevention, Vancouver,
Canada, July 2015
INSIGHT START Study Group, The START study: design, conduct and main results
--
Slides
Conference on Retroviruses and Opportunistic Infections (CROI) 2015,
Seattle, Washington, February 2015
Achhra AC et al, Pre-therapy inflammation and long-term CD4 response to
antiretroviral therapy --
Abstract |
Poster
Borges Á et al, IL-6 is a stronger predictor of clinical events than
hsCRP or D-dimer in HIV disease --
Abstract
| Poster
XXIV International HIV Drug Resistance Workshop, Seattle, Washington,
February 2015
Baxter JD et al, Global HIV-1 transmitted drug resistance in the INSIGHT
Strategic Timing of AntiRetroviral Treatment study --
Abstract
| Poster
